Home Business FTC Takes Action Against Pharmacies Inflating Insulin Prices

FTC Takes Action Against Pharmacies Inflating Insulin Prices

by Sonia Park
0 comment
FTC Takes Action Against Pharmacies Inflating Insulin Prices

The Federal Trade Commission (FTC) has launched a major investigation against three of the nation's largest pharmacy benefit managers (PBMs) for allegedly inflating insulin prices, leaving patients across the U.S. facing exorbitant costs for the life-saving medication. The targeted PBMs, CVS Health’s Caremark Rx, Cigna’s Express Scripts, and UnitedHealth Group’s OptumRx, are accused of creating a pricing system that prioritizes profit over patient care.

https://youtu.be/UNwB2Kcao0k

According to the FTC, the companies orchestrated a scheme that significantly raised the list prices for insulin by favoring higher. . .

You have exceeded the number of free content views. To continue viewing exclusive JudgeNap content,  you'll need a subscription. Please choose your subscription plan here.

Already a member?  Login here.

You may also like

Leave a Comment

Our Company

Judge Andrew P. Napolitano – Judging Freedom – JudgeNap.com

Newsletter

Subscribe to the Judging Freedom Newsletter and stay updated!

Laest News

@2023 – All Right Reserved. Designed and Developed by:

 Christopher Leonard – OMG Media Partners, LLC.

-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00